Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

TATTON: Updated results for patients with EGFR-mutant NSCLC

Prof Leica Sequist - Massachusetts General Hospital, Boston, USA
TATTON: Updated results for patients with EGFR-mutant NSCLC ( Prof Leica Sequist - Massachusetts General Hospital, Boston, USA )
11 Apr 2019

Mesothelin-targeted CAR T-cell therapy safe, shows early promise in patients with advanced solid tumours

Dr Prasad Adusumilli - Memorial Sloan Kettering Cancer Center, New York, USA
Mesothelin-targeted CAR T-cell therapy safe, shows early promise in patients with advanced solid tumours ( Dr Prasad Adusumilli - Memorial Sloan Kettering Cancer Center, New York, USA )
11 Apr 2019

HER2-targeted CAR T-cell therapy safe and showing promising antitumour activity in patients with advanced sarcoma

Prof Shoba Navai - Baylor College of Medicine, Houston, USA
HER2-targeted CAR T-cell therapy safe and showing promising antitumour activity in patients with advanced sarcoma ( Prof Shoba Navai - Baylor College of Medicine, Houston, USA )
11 Apr 2019

Umbralisib shows early promise for patients with marginal zone lymphoma

Prof Nathan Fowler - MD Anderson Cancer Center, Houston, USA
Umbralisib shows early promise for patients with marginal zone lymphoma ( Prof Nathan Fowler - MD Anderson Cancer Center, Houston, USA )
11 Apr 2019

KEYNOTE trials show pembrolizumab benefited patients with advanced small cell lung cancer

Prof Hyun Cheol Chung - Yonsei University, Seoul, South Korea
KEYNOTE trials show pembrolizumab benefited patients with advanced small cell lung cancer ( Prof Hyun Cheol Chung - Yonsei University, Seoul, South Korea )
11 Apr 2019

Gilteritinib improved survival for patients with acute myeloid leukaemia

Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA
Gilteritinib improved survival for patients with acute myeloid leukaemia ( Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA )
11 Apr 2019

New developments in soft tissue and bone sarcoma research

Prof Hans Gelderblom - Universiteit Leiden, Leiden, Netherlands
New developments in soft tissue and bone sarcoma research ( Prof Hans Gelderblom - Universiteit Leiden, Leiden, Netherlands )
21 Mar 2019

Latest updates in melanoma research

Dr Alexander van Akkooi - The Netherlands Cancer Institute, Amsterdam, Netherlands
Latest updates in melanoma research ( Dr Alexander van Akkooi - The Netherlands Cancer Institute, Amsterdam, Netherlands )
21 Mar 2019

Gynaecological cancer: Where are we now?

Dr Nelleke Ottevanger - Radboud University Medical Center, Nijmegen, Netherlands
Gynaecological cancer: Where are we now? ( Dr Nelleke Ottevanger - Radboud University Medical Center, Nijmegen, Netherlands )
21 Mar 2019

Sequencing Sorafenib and Regorafenib in advanced hepatocellular carcinoma – Brought to you by Oncology Knowledge into Practice

Prof Josep Llovet, Dr Richard Finn
Sequencing Sorafenib and Regorafenib in advanced hepatocellular carcinoma – Brought to you by Oncology Knowledge into Practice ( Prof Josep Llovet, Dr Richard Finn )
25 Feb 2019

CB-839 in combination with cabozantinib in patients with clear cell and papillary metastatic renal cell cancer

Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA
CB-839 in combination with cabozantinib in patients with clear cell and papillary metastatic renal cell cancer ( Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA )
18 Feb 2019

CheckMate 214: Nivolumab, ipilimumab or sunitinib in patients with advanced renal cell carcinoma

Prof Nizar Tannir - MD Anderson Cancer Center, Houston, USA
CheckMate 214: Nivolumab, ipilimumab or sunitinib in patients with advanced renal cell carcinoma ( Prof Nizar Tannir - MD Anderson Cancer Center, Houston, USA )
16 Feb 2019